Equillium Inc
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Trading Arrangements
During the three-months ended December 31, 2023, one of our executive officers adopted a trading plan for the orderly disposition of our securities set forth in the table below:
| Type of Trading Arrangement · Total Sharesof Common | |||||
|---|---|---|---|---|---|
| Name and Position · Action · Adoption/TerminationDate · Rule10b5-1(1) · Non-Rule10b5-1(2) · Stock to beSold · Expiration Date | |||||
| Christine Zedelmayer, Chief Operating Officer | Adoption | December 12, 2023 | X | 322,823 | December 12, 2024 |
(1) Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
(2) “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.